Xcel Wealth Management LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH) - Modern Readers

This post was originally published on link to post

Xcel Wealth Management LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,671 shares of the healthcare conglomerate’s stock after selling 300 shares during the quarter. Xcel Wealth Management LLC’s holdings in UnitedHealth Group were worth $936,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Carroll Financial Associates Inc. grew its position in shares of UnitedHealth Group by 0.9% in the 4th quarter. Carroll Financial Associates Inc. now owns 3,200 shares of the healthcare conglomerate’s stock worth $1,122,000 after buying an additional 30 shares during the period. Ellis Investment Partners LLC increased its stake in shares of UnitedHealth Group by 5.6% in the 3rd quarter. Ellis Investment Partners LLC now owns 602 shares of the healthcare conglomerate’s stock worth $187,000 after acquiring an additional 32 shares in the last quarter. Pointe Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Pointe Capital Management LLC now owns 1,987 shares of the healthcare conglomerate’s stock worth $619,000 after acquiring an additional 32 shares in the last quarter. AMJ Financial Wealth Management grew its position in UnitedHealth Group by 1.6% during the 3rd quarter. AMJ Financial Wealth Management now owns 2,206 shares of the healthcare conglomerate’s stock valued at $688,000 after purchasing an additional 34 shares during the last quarter. Finally, Signature Wealth Management Group grew its position in UnitedHealth Group by 1.2% during the 3rd quarter. Signature Wealth Management Group now owns 2,756 shares of the healthcare conglomerate’s stock valued at $859,000 after purchasing an additional 34 shares during the last quarter. 86.39% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently commented on the stock. Mizuho increased their price objective on shares of UnitedHealth Group from $361.00 to $380.00 and gave the company a “buy” rating in a research report on Monday, November 9th. BidaskClub raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Saturday. Barclays increased their price objective on shares of UnitedHealth Group from $322.00 to $365.00 and gave the company an “overweight” rating in a research report on Tuesday, October 13th. SVB Leerink increased their price objective on shares of UnitedHealth Group from $378.00 to $390.00 and gave the company an “outperform” rating in a research report on Monday, December 14th. Finally, JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $360.00 to $430.00 in a research report on Wednesday, December 2nd. Seven research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $383.50.

Shares of NYSE:UNH traded down $4.57 during trading on Wednesday, hitting $352.80. The company’s stock had a trading volume of 65,422 shares, compared to its average volume of 3,611,805. The company has a 50-day moving average of $344.91 and a 200-day moving average of $322.55. UnitedHealth Group Incorporated has a 12 month low of $187.72 and a 12 month high of $367.95. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.84. The firm has a market cap of $334.74 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 1.53 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. During the same quarter in the prior year, the business earned $3.88 EPS. The business’s quarterly revenue was up 7.9% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 16.78 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.42%. The ex-dividend date of this dividend was Friday, December 4th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, December 10th. The shares were sold at an average price of $342.00, for a total transaction of $855,000.00. Following the sale, the director now owns 159,487 shares in the company, valued at approximately $54,544,554. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 7,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total transaction of $2,448,460.00. Following the sale, the director now owns 159,487 shares in the company, valued at approximately $55,785,362.86. The disclosure for this sale can be found here. Insiders sold a total of 130,253 shares of company stock worth $43,485,730 in the last quarter. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children’s Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Further Reading: CBOE Russell 2000® Volatility Index

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).



Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.